SEC Tracker
Get the app

Acura Pharmaceuticals

Acura Pharmaceuticals: late notice: the 10-Q for the quarter ended Mar 31, 2024 will be filed late

Form
NT 10-Q
Filed
Period
Importance
Notable
Document
NT 10-Q

Not explained yet; the original is on EDGAR.

Late notice: the 10-Q for the quarter ended Mar 31, 2024 will be filed late

View on EDGAR

Open in the app

Get an email when Acura Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Ayala Pharmaceuticals ADXS
  2. Ampio Pharmaceuticals AMPE
  3. Alterity Therapeutics ATHE
  4. Adhera Therapeutics ATRX
  5. Avricore Health AVCRF